These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13490810)

  • 1. [Clinical research on the treatment of diabetic tuberculotics with sulfonylurea].
    VERGANI F; CAMURATI E; CAZZANI E
    G Ital Della Tuberc; 1957; 11(5):311-6. PubMed ID: 13490810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with sulfonylurea therapy in tuberculosis of diabetic patients].
    MARTON S; BANYASZ T; MEDVECZKY E
    Orv Hetil; 1958 Jun; 99(26):878-84. PubMed ID: 13566802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of sulfonylurea derivatives in diabetes mellitus associated with pulmonary tuberculosis].
    LAURIA D; LIOTTI G; SCOGNAMILLO A
    Riforma Med; 1958 Jun; 72(26):724-7. PubMed ID: 13579942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of clinical use of tolbutamide in diabetic tuberculosis patients].
    DADDI G; GRASSI C
    Minerva Med; 1958 Apr; 49(30):1397-9. PubMed ID: 13552267
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methylbutylurea treatment of diabetics with pulmonary tuberculosis].
    FILLA E; FILOGRANA V
    Minerva Med; 1958 Sep; 49(71):3333-6. PubMed ID: 13600137
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental and clinical studies on the use of sulfonyl ureas in tuberculous diabetics].
    GRASSI-GIALDRONI G; VERGANI F; CAMURATI E; CAZZANI E; GRASSI C
    Minerva Med; 1958 Apr; 49(31):1506. PubMed ID: 13552325
    [No Abstract]   [Full Text] [Related]  

  • 7. [N-sulfanilyl-N'-butyl urea (BZ55) therapy of diabetes in patients of pulmonary tuberculosis].
    LENCI E
    Minerva Med; 1958 Apr; 49(31):1482-4. PubMed ID: 13552304
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of N1-sulfanilylo-N2-n-butyl-carbamide in diabetes complicated by tuberculosis].
    LITYNSKI M
    Pol Tyg Lek (Wars); 1957 Jun; 12(23):880-4. PubMed ID: 13465394
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of associated diabetes & tuberculosis with peroral antidiabetics].
    REALE M; ANSELMO B; BASSO L; SICCARDI L
    Gazz Med Ital; 1959 Feb; 118(2):51-8. PubMed ID: 13653340
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of the insulin-glucose test for qualifying diabetic patients for treatment with sulfonylurea preparations].
    LITYNSKI M
    Pol Tyg Lek (Wars); 1958 Aug; 13(33):1272-6. PubMed ID: 13613994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with chloropropamide (diabinese) in average cases of diabetes complicated by active pulmonary tuberculosis].
    GAGALA M; LEWARTOWSKI B
    Pol Tyg Lek; 1960 Dec; 15():1919-22. PubMed ID: 13702911
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemic sulfamides as treatment of diabetic tuberculous patients].
    LOUSTAU-CHARTEZ M; VASSEUR B
    Presse Med (1893); 1958 Jun; 66(45):1022-3. PubMed ID: 13567507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alcoholism in pulmonary tuberculotics; a medico-psychological study in a tuberculosis sanatorium].
    MERKEL KL
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 116(8):653-76. PubMed ID: 13445648
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with bis(p-acetoxyphenyl)-2-pyridylmethane (dulcoax Boehringer) in the treatment of constipation in bedfast tuberculotics].
    DE ALEMQUER M; HERDEIRO J
    Gaz Med Port; 1958; 11(5):627-30. PubMed ID: 13620046
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results of one year of treatment of diabetic patients with hypoglycemic sulfonamides].
    VITELLI A; GAIDANO G; PAGLIARDI E; D'URSO A
    Minerva Med; 1958 Apr; 49(31):1459-60. PubMed ID: 13552283
    [No Abstract]   [Full Text] [Related]  

  • 18. [Asymptomatic adrenal tuberculosis; its frequency and importance in surgery of pulmonary tuberculosis; statistical findings in 2,000 autopsies of pulmonary tuberculotics].
    TUSINI G
    Biol Lat; 1956; 9(1):48-60. PubMed ID: 13341996
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study.
    Herman WH; Dirani RG; Horblyuk R; O'Neill MC; Kravitz B; Heise MA; Bakst A; Freed MI;
    Am J Manag Care; 2005 Apr; 11(4):273-8. PubMed ID: 15839187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with sulfonylurea compounds in diabetes.
    MARBLE A; CAMERINI-DAVALOS R
    Ann N Y Acad Sci; 1957 Jul; 71(1):239-48. PubMed ID: 13459220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.